Advanced search
Start date
Betweenand

Role of pancreatic mesenchymal stromal cells in the pathogenesis of autoimune diabetes

Grant number: 12/50768-0
Support type:Regular Research Grants
Duration: January 01, 2014 - June 30, 2016
Field of knowledge:Biological Sciences - Immunology
Cooperation agreement: CNPq - First Projects Program
Principal Investigator:Kelen Cristina Ribeiro Malmegrim de Farias
Grantee:Kelen Cristina Ribeiro Malmegrim de Farias
Home Institution: Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP). Universidade de São Paulo (USP). Ribeirão Preto , SP, Brazil

Abstract

Multipotent mesenchymal stromal cells are found in the stroma of all adult tissue and probably located at the perivascular niche. Due to their location, regenerative, immunossupressive and immunoregulatory properties, it has been suggested that these cells work like in vivo stromal sentinels inhibiting potential inflammatory tissue-destructive responses and regulating tissue regeneration. In the last years, populations of pancreatic mesenchymal stromal cells (pMSCs) were reported in endocrine and exocrine pancreatic tissue cultures. Nevertheless, there are no conclusive results regarding their in vivo location, true origin, and role in the pancreatic tissue. Thus, the hypothesis of this work is that pMSCs share biological and immunoregulatory characteristics with other stromal populations, and also undergo continuous modulation by the pancreatic microenvironment during ali phases of experimental autoimmune diabetes development and progression. The objective of this project is to study the role of pancreatic mesenchymal stromal cells in the pathogenesis of experimental autoimmune diabetes. For that, we have established specific goals: 1, To isolate and characterize pMSCs from BALB/c mice; 2, To characterize freshly isolated pMSCs from BALB/c mice by flow cytometry sorting; 3, To determine the mechanisms involved in the immunossupressive and immunoregulatory properties of pMSCs; 4, To investigate the effects of hyperglycemia in the immunossupressive and immunoregulatory properties of pMCSs; 5, To determine the involvement of pMSCs during the development and pathogenesis of experimental autoimmune diabetes; 6, To determine the in situ location of pMSCs in control BALB/c mice and in all phases of experimental autoimmune diabetes development in NOD mice. (AU)